[HTML][HTML] CXCR4-targeted theranostics in oncology
AK Buck, SE Serfling, T Lindner, H Hänscheid… - European Journal of …, 2022 - Springer
A growing body of literature reports on the upregulation of CXC motif chemokine receptor 4 (CXCR4)
in a variety of cancer entities, rendering this receptor as suitable target for …
in a variety of cancer entities, rendering this receptor as suitable target for …
Imaging of CXC motif chemokine receptor 4 expression in 690 patients with solid or hematologic neoplasms using 68Ga-pentixafor PET
…, M Fassnacht, H Einsele, SE Serfling… - Journal of Nuclear …, 2022 - Soc Nuclear Med
In recent years, molecular imaging addressing the CXC motif chemokine receptor 4 (CXCR4)
has increasingly been used in various clinical settings. Here, we aimed to assess …
has increasingly been used in various clinical settings. Here, we aimed to assess …
[HTML][HTML] Radioligands targeting fibroblast activation protein (FAP)
T Lindner, FL Giesel, C Kratochwil, SE Serfling - Cancers, 2021 - mdpi.com
Simple Summary FAP-targeted radiotracers, recently introduced in cancer treatment, accumulate
in Cancer-Associated Fibroblasts (CAFs). CAFs are present in tumor lesions but do not …
in Cancer-Associated Fibroblasts (CAFs). CAFs are present in tumor lesions but do not …
[HTML][HTML] Impact of 68Ga-FAPI-04 PET/CT on staging and therapeutic management in patients with digestive system tumors
A Kosmala, SE Serfling, W Schlötelburg… - Clinical Nuclear …, 2023 - journals.lww.com
… E-mail: [email protected]. … Bray F, Laversanne M, Weiderpass E, et al. The ever-increasing
importance of cancer as a leading cause of premature death worldwide. Cancer. … Serfling …
importance of cancer as a leading cause of premature death worldwide. Cancer. … Serfling …
[HTML][HTML] Prostate-specific membrane antigen reporting and data system version 2.0
RA Werner, PE Hartrampf, WP Fendler, SE Serfling… - European urology, 2023 - Elsevier
Prostate-specific Membrane Antigen Reporting and Data System (PSMA-RADS) was introduced
for standardized reporting, and PSMA-RADS version 1.0 allows classification of lesions …
for standardized reporting, and PSMA-RADS version 1.0 allows classification of lesions …
CXC motif chemokine receptor 4–targeted radioligand therapy in patients with advanced T-cell lymphoma
…, S Samnick, H Einsele, SE Serfling… - Journal of Nuclear …, 2023 - Soc Nuclear Med
CXC motif chemokine receptor 4 (CXCR4)–targeted radioligand therapy (RLT) has already
been applied to advanced blood cancers, such as multiple myeloma or diffuse large B-cell …
been applied to advanced blood cancers, such as multiple myeloma or diffuse large B-cell …
[HTML][HTML] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
PE Hartrampf, FX Weinzierl, SE Serfling, MG Pomper… - Cancers, 2022 - mdpi.com
Simple Summary Radioligand therapy (RLT) with prostate-specific membrane antigen (PSMA)-directed
agents has shown remarkable results in patients with advanced prostate cancer. …
agents has shown remarkable results in patients with advanced prostate cancer. …
Theranostics in hematooncology
In the early 2000s, major clinical trials provided evidence of a favorable outcome from
antibody-mediated radioimmunotherapy for hematologic neoplasms, which then led to Food and …
antibody-mediated radioimmunotherapy for hematologic neoplasms, which then led to Food and …
[HTML][HTML] [18F] DCFPyL PET/CT for imaging of prostate cancer
…, RA Bundschuh, C Lapa, SE Serfling… - Nuklearmedizin …, 2022 - thieme-connect.com
Prostate-specific membrane antigen (PSMA)-directed positron emission tomography (PET)
has gained increasing interest for imaging of men affected by prostate cancer (PC). In recent …
has gained increasing interest for imaging of men affected by prostate cancer (PC). In recent …
[HTML][HTML] CXCR4-directed PET/CT in patients with newly diagnosed neuroendocrine carcinomas
We aimed to elucidate the diagnostic potential of the CXC motif chemokine receptor 4 (CXCR4)-directed
positron emission tomography (PET) tracer 68 Ga-Pentixafor in patients with …
positron emission tomography (PET) tracer 68 Ga-Pentixafor in patients with …